Latest Breaking News On - Global healthcare company contributing - Page 1 : vimarsana.com

American Regent Introduces Potassium Phosphates, USP; FDA-Approved and AP Rated¹

/PRNewswire/ American Regent announces the launch and availability of Potassium Phosphates Injection, USP, which is FDA-approved and therapeutically.

United statesNew yorkJoann gioiaDaiichi sankyoIntravenous administrationLaboratory monitoringAmerican regent incDaiichi sankyo groupUs food drug administrationInnovative global healthcare companyCustomer support groupSustainable development of societyPotassium phosphates injectionPhosphates injectionVice presidentChief commercial officer

Datopotamab Deruxtecan Combinations Showed Encouraging Tumor Responses in Patients with Advanced Non-Small Cell Lung Cancer in TROPION-Lung02 Phase 1b trial

In previously untreated patients, Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus pembrolizumab with or without platinum chemotherapy demonstrated objective response rates of 57%. | June 5, 2023

United statesMark rutsteinAnn oncCristian massacesiDaiichi sankyoSarah cannon research instituteAmerican cancer societyMerck co incSapporo medical universityAmerican society of clinical oncology annual meetingInternational agency for research on cancerSustainable development of societyNational cancer center hospitalInnovative global healthcare companyDivision of internal medicineOncology clinical development

INJECTAFER® Approved in the U S for the Treatment of Iron Deficiency in Adult Patients with Heart Failure

INJECTAFER is now the first and only intravenous iron replacement therapy indicated for adult patients with heart failure who have iron deficiency . | June 5, 2023

New yorkUnited statesRavi tayiDaiichi sankyoDrug administrationDaiichi sankyo groupEuropean unionInnovative global healthcare companyLuitpold pharmaceuticals incAdverse drug events to american regent incPharmaceuticals incAmerican heart associationYork heart associationAmerican regent incDaiichi sankyo incPharmacosmos therapeutics inc

Daiichi Sankyo Showcases Latest Research Towards Creating New Standards of Care for Patients with Cancer with Data at ASCO and EHA

Daiichi Sankyo Showcases Latest Research Towards Creating New Standards of Care for Patients with Cancer with Data at ASCO and EHA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaiichi sankyoKoji ogiwaraKen takeshitaDatopotamab deruxtecanJennifer brennanDaiichi sankyo incSustainable development of societyInnovative global healthcare companySarah cannon research instituteDaiichi sankyo co ltdAmerican society of clinical oncology scientific programEuropean hematology association congressClinical oncology scientific programGlobal headDeruxtecan based combinations continuing

Stock Market | FinancialContent Business Page

FinancialContent fully hosted finance channel

United statesDaiichi sankyoKen takeshitaDatopotamab deruxtecanSustainable development of societyAmerican society of clinical oncology scientific programEuropean hematology association congressInnovative global healthcare companySarah cannon research instituteDaiichi sankyo incClinical oncology scientific programGlobal headDeruxtecan based combinations continuingShow promiseOncomine dx targetPresentation monday